对帕金森病中姿势平衡的趋势变化分析区分了药物状态
Piotr Wodarski1, Jacek Jurkojć1, Marta Chmura1
1Faculty of Biomedical Engineering, Department of Biomechatronics, Silesian University of Technology, Gliwice, Poland.
Journal of neuroengineering and rehabilitation
|June 29, 2024
概括
使用惯性测量单位 (IMU) 的趋势变化分析 (TCA) 有效地区分了帕金森病 (pwPD) 患者的药物状态. 这种方法提供了一种新的方法来评估神经疾病中的姿势摇摆和潜在的治疗反应.
科学领域:
- 生物力学 生物力学
- 神经学 神经学
- 医疗技术 医疗技术 医学技术
背景情况:
- 静态平衡依赖于部门间的协调,这对日常活动至关重要.
- 姿势能力受损增加了跌倒的风险,特别是在患有帕金森病 (pwPD) 的人群中.
- pwPD会表现出运动症状,影响着姿势的稳定性.
研究的目的:
- 评估趋势变化分析 (TCA) 用于用惯性测量单位 (IMU) 评估姿势稳定性的实用性.
- 应用TCA来区分pwPD和健康成年人之间的运动策略.
- 研究TCA在理解神经疾病进展,特别是帕金森病方面的潜力.
主要方法:
- 包括61名健康成年人 (40名年轻人,21名老人) 和29名pwPD (药物停用/开启).
- 参与者从短物理性能电池执行了10秒的安静姿势任务.
- 头部,胸骨和腰部的IMU捕获了姿势数据;TCA用于组比较.
主要成果:
- 传感器位置在所有组中都对大多数姿势参数产生了重大影响.
- 在pwPD中,TCA发现了药物启用和药物停用状态之间的差异,而其他参数没有检测到这些差异.
结论:
- 与其他分析的参数不同,TCA有效地区分了pwPD中的药物状态.
- 传感器位置是影响姿势摇摆评估的关键因素.
- 未来的研究应该探索TCA来评估帕金森病的进展和治疗疗效.
相关概念视频
01:24Parkinson's Disease: Treatment
254
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
254
01:15Parkinson's Disease: Overview
523
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
523